Climb Bio, Inc.
Clinical-stage biotech developing therapies for immune-mediated diseases.
CLYM | US
Overview
Corporate Details
- ISIN(s):
- US28658R1068
- LEI:
- Country:
- United States of America
- Address:
- 20 WILLIAM STREET, 2481 WELLESLEY HILLS
- Website:
- https://climbbio.com/
Description
Climb Bio, Inc. is a clinical-stage biotechnology company that develops therapeutics for patients with immune-mediated diseases. The company's mission is to deliver high-impact, disease-modifying medicines, with a scientific approach centered on developing differentiated monoclonal antibodies. Its pipeline includes investigational therapies for diseases with limited therapeutic options, which are being advanced through clinical studies across multiple areas to evaluate their potential to improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Climb Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Climb Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Climb Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
